Skip to main content

Table 1 Demographic characteristics of patients with PTC who underwent TOETVA

From: Safety and feasibility of the transoral endoscopic thyroidectomy vestibular approach with neuroprotection techniques for papillary thyroid carcinoma

Variables

Value

Age

36.8 ± 10.5 (20–65)

Sex (female/male)

66/9

BMI

22.3 ± 3.5 (15.8–34.3)

BMI ≥ 25

13

Operation type, n (%)

 

 Total thyroidectomy with CND

17 (22.7)

 Lobectomy with CND

58 (77.3)

Tumor size (cm)

0.83 ± 0.66 (0.1–3.5)

Postoperative stage, n (%)

 

 T1

69 (92.0)

 T2

3 (4.0)

 T3b

3 (4.0)

Hospital stay (days)

3.8 ± 1.1 (2–8)

Drainage time (days)

2.8 ± 1.1 (1–7)

Blood loss (mL)

21.1 ± 17.3 (5–100)

Operation time (min)

140.1 ± 48.4 (65–295)

 Total thyroidectomy with CND

165.1 ± 44.0 (70–237)

 Lobectomy with CND

132.7 ± 47.5 (65–295)

Retrieved lymph nodes

6.8 ± 3.9 (0–17)

Positive lymph nodes

1.5 ± 2.3 (0–11)

  1. PTC papillary thyroid carcinoma, TOETVA trans-oral endoscopic thyroidectomy vestibular approach, CND central neck dissection